Transdermal delivery of Chinese herbal medicine extract using dissolvable microneedles for hypertrophic scar treatment
暂无分享,去创建一个
[1] S. El Andaloussi,et al. Smad-binding decoy reduces extracellular matrix expression in human hypertrophic scar fibroblasts , 2020, Molecular medicine reports.
[2] Christian Wiraja,et al. A Double‐Layered Microneedle Platform Fabricated through Frozen Spray‐Coating , 2020, Advanced healthcare materials.
[3] Ramesh C. Gupta,et al. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory , 2019, Front. Vet. Sci..
[4] M. M. Pandey,et al. Microneedles: A smart approach and increasing potential for transdermal drug delivery system. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Christian Wiraja,et al. Anti-Scarring Drug Screening with Near-Infrared Molecular Probes Targeting Fibroblast Activation Protein-α. , 2018, ACS applied bio materials.
[6] Christian Wiraja,et al. Oligonucleotide Molecular Sprinkler for Intracellular Detection and Spontaneous Regulation of mRNA for Theranostics of Scar Fibroblasts. , 2018, Small.
[7] Ning Zhang,et al. Development of a Porcine Full-Thickness Burn Hypertrophic Scar Model and Investigation of the Effects of Shikonin on Hypertrophic Scar Remediation , 2018, Front. Pharmacol..
[8] C. Cao,et al. MicroRNA-98 inhibits the cell proliferation of human hypertrophic scar fibroblasts via targeting Col1A1 , 2017, Biological Research.
[9] M. Kim,et al. Evaluation of the anti‐wrinkle effect of an ascorbic acid‐loaded dissolving microneedle patch via a double‐blind, placebo‐controlled clinical study , 2016, International journal of cosmetic science.
[10] Z. Upton,et al. Investigating the potential of Shikonin as a novel hypertrophic scar treatment , 2015, Journal of Biomedical Science.
[11] D. Leavesley,et al. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts , 2015, International journal of molecular medicine.
[12] K. Rahman,et al. Medicinal Plants for the Treatment of Hypertrophic Scars , 2015, Evidence-based complementary and alternative medicine : eCAM.
[13] D. Leavesley,et al. Functional and mechanistic investigation of Shikonin in scarring. , 2015, Chemico-biological interactions.
[14] Qing-wang Han,et al. The Four-Herb Chinese Medicine ANBP Enhances Wound Healing and Inhibits Scar Formation via Bidirectional Regulation of Transformation Growth Factor Pathway , 2014, PloS one.
[15] Felipe Bettini Rabello,et al. Update on hypertrophic scar treatment , 2014, Clinics.
[16] I. Vovk,et al. Addition of β-lactoglobulin produces water-soluble shikonin. , 2012, Journal of agricultural and food chemistry.
[17] A. Grobbelaar,et al. The role of the TGF-β family in wound healing, burns and scarring: a review. , 2012, International journal of burns and trauma.
[18] Shu-peng Li,et al. A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine , 2011, Archives of pharmacal research.
[19] Cai Baochang,et al. Advances in studies on nano-technology applied in Chinese materia medica , 2011 .
[20] A. Bayat,et al. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option , 2010, Archives of Dermatological Research.
[21] G. Juckett,et al. Management of keloids and hypertrophic scars. , 2009, American Family Physician.
[22] C. Turner,et al. Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop. , 2008, The Journal of investigative dermatology.
[23] M Kon,et al. On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.